(HealthDay)—For cancer screening in Medicare beneficiaries, there is substantial agreement for different prognostic tools for short- and long-term survival, according to a study published online April 30 in the Journal ...
May 11, 2016
0
1
US biotech company Medivation has opened the door to being bought by either Pfizer or Amgen, a person familiar with the matter told AFP Tuesday.
May 10, 2016
0
1
US authorities said Wednesday that drug giant Pfizer had agreed to pay nearly $785 million to settle allegations that one of its units overcharged the government for anti-acid drugs.
Apr 27, 2016
0
4
Top U.S. drugmaker Pfizer and Irish rival Allergan are charting independent futures after scrapping a record $160 billion deal torpedoed by new Treasury Department rules meant to block American companies from moving their ...
Apr 6, 2016
0
1
Brazil has signed an agreement with a Texas research hospital to develop a vaccine against the Zika virus, the country's health minister said Thursday, adding the goal is for the vaccine to be ready for clinical testing within ...
Feb 11, 2016
0
3
Cancer screening could soon be as simple as giving a urine sample using a patented device developed by a Missouri University of Science and Technology researcher. This week, Wyoming-based Cancer.im Inc., a Viratech Corp. ...
Feb 3, 2016
0
45
School meals could become a bit tastier under legislation approved by a Senate committee.
Jan 20, 2016
0
3
Recepta Biopharma, a Brazilian company, has signed a licensing agreement with Mersana Therapeutics, under which the US-based company's technology will be used to produce a monoclonal antibody (mAb) that can be deployed for ...
Aug 10, 2015
0
11
In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...
May 7, 2015
0
10
Sanford-Burnham Medical Research Institute (Sanford-Burnham) today announced that it has signed a licensing agreement to further develop a first-in-class small molecule with Daiichi Sankyo for the treatment of cardiovascular-metabolic ...
Apr 2, 2015
0
3
